@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP953887.RA_ozBdIsY2_cHyd_ubruG6IbJMACwQ339S-_xf2rdoSk130_head { this: np:hasAssertion dgn-np:NP953887.RA_ozBdIsY2_cHyd_ubruG6IbJMACwQ339S-_xf2rdoSk130_assertion; np:hasProvenance dgn-np:NP953887.RA_ozBdIsY2_cHyd_ubruG6IbJMACwQ339S-_xf2rdoSk130_provenance; np:hasPublicationInfo dgn-np:NP953887.RA_ozBdIsY2_cHyd_ubruG6IbJMACwQ339S-_xf2rdoSk130_publicationInfo; a np:Nanopublication . dgn-np:NP953887.RA_ozBdIsY2_cHyd_ubruG6IbJMACwQ339S-_xf2rdoSk130_assertion a np:Assertion . dgn-np:NP953887.RA_ozBdIsY2_cHyd_ubruG6IbJMACwQ339S-_xf2rdoSk130_provenance a np:Provenance . dgn-np:NP953887.RA_ozBdIsY2_cHyd_ubruG6IbJMACwQ339S-_xf2rdoSk130_publicationInfo a np:PublicationInfo . } dgn-np:NP953887.RA_ozBdIsY2_cHyd_ubruG6IbJMACwQ339S-_xf2rdoSk130_assertion { miriam-gene:3586 a ncit:C16612 . lld:C0002875 a ncit:C7057 . dgn-gda:DGN4294d83fdb91b90a60621af6fe0ca47e sio:SIO_000628 miriam-gene:3586, lld:C0002875; a sio:SIO_001121 . } dgn-np:NP953887.RA_ozBdIsY2_cHyd_ubruG6IbJMACwQ339S-_xf2rdoSk130_provenance { dgn-np:NP953887.RA_ozBdIsY2_cHyd_ubruG6IbJMACwQ339S-_xf2rdoSk130_assertion dcterms:description "[In this study, the impact of polymorphisms in the genes of proinflammatory (IL-β, TNF-α, IL-6, IFN-γ), anti-inflammatory (transforming growth factor [TGF]-β, IL-10, IL-Ra), and other immunoregulatory factors (FcγRIIa, NOS3) along with the conventional risk factors on the rate of hematopoietic recovery and first episodes of bacterial, viral, or invasive fungal infections in 102 patients with β-thalassaemia major who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) with relatively uniform protocols at our center from June 1995 to June 2004 with a minimum follow-up of at least 2 years were studied retrospectively for 180 days after hematopoietic stem cell transplantation (HSCT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:22252124; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP953887.RA_ozBdIsY2_cHyd_ubruG6IbJMACwQ339S-_xf2rdoSk130_publicationInfo { this: dcterms:created "2016-05-13T12:48:57+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }